Cargando…
Safety, Immunogenicity and Dose Ranging of a New Vi-CRM(197) Conjugate Vaccine against Typhoid Fever: Randomized Clinical Testing in Healthy Adults
BACKGROUND: Typhoid fever causes more than 21 million cases of disease and 200,000 deaths yearly worldwide, with more than 90% of the disease burden being reported from Asia. Epidemiological data show high disease incidence in young children and suggest that immunization programs should target child...
Autores principales: | van Damme, Pierre, Kafeja, Froukje, Anemona, Alessandra, Basile, Venere, Hilbert, Anne Katrin, De Coster, Ilse, Rondini, Simona, Micoli, Francesca, Qasim Khan, Rana M., Marchetti, Elisa, Di Cioccio, Vito, Saul, Allan, Martin, Laura B., Podda, Audino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184126/ https://www.ncbi.nlm.nih.gov/pubmed/21980445 http://dx.doi.org/10.1371/journal.pone.0025398 |
Ejemplares similares
-
O:2-CRM(197) Conjugates against Salmonella Paratyphi A
por: Micoli, Francesca, et al.
Publicado: (2012) -
Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM(197) conjugate vaccine
por: Micoli, Francesca, et al.
Publicado: (2020) -
Click chemistry compared to thiol chemistry for the synthesis of site-selective glycoconjugate vaccines using CRM(197) as carrier protein
por: Stefanetti, G., et al.
Publicado: (2020) -
Investigating the Deoxyribonuclease Activity of CRM197
with Site-Directed Mutagenesis
por: Bravo-Bautista, Nathalie, et al.
Publicado: (2019) -
Efficient recovery of recombinant CRM197 expressed as inclusion bodies in E.coli
por: Park, Ah-Reum, et al.
Publicado: (2018)